New Advances in Dyslipidemia
Dyslipidemia is an important risk factor for atherosclerotic cardiovascular disease (ASCVD). However, despite current traditional therapies (e.g., statins), significant residual risks for the onset of ASCVD remain, warranting the need to better understand newer therapeutic options for diminishing t...
Збережено в:
| Формат: | Online |
|---|---|
| Мова: | Англійська |
| Опубліковано: |
MDPI - Multidisciplinary Digital Publishing Institute
2024
|
| Предмети: | |
| Онлайн доступ: | ONIX_20240514_9783036598710_98 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
Схожі ресурси: New Advances in Dyslipidemia
- New Lipid Lowering Therapies for Cardiovascular and Metabolic Diseases: Lessons from the Past and Future Challenges
- Novel Aspects of Lipoprotein Metabolism with Focus on Systemic Inflammation
- Diets, Foods and Food Components Effect on Dyslipidemia
- The Prevention and Treatment of Atherosclerosis
- Endothelial Dysfunction: From Pathophysiology to Novel Therapeutic Approaches
- The Effect of Diet on Cardiovascular Disease, Heart Disease and Blood Vessels